GSK plc
F:GS70
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GSK plc
F:GS70
|
UK |
|
Koninklijke Vopak NV
F:VPK5
|
NL |
|
S
|
SNC-Lavalin Group Inc
OTC:SNCAF
|
CA |
|
Worthington Steel Inc
F:Z2J
|
US |
|
K
|
Kohls Corp
F:KHP
|
US |
|
S
|
Shandong Weigao Group Medical Polymer Co Ltd
SWB:UK2
|
CN |
|
Zinc of Ireland NL
ASX:ZMI
|
AU |
|
C
|
Carnegie Clean Energy Ltd
F:CNM1
|
AU |
|
Compagnie du Bois Sauvage SA
XBRU:COMB
|
BE |
|
E
|
Enerflex Ltd
F:7EX
|
CA |
|
A
|
Aptamer Group PLC
F:P0J
|
UK |
|
Nisshin OilliO Group Ltd
OTC:NSOMF
|
JP |
|
J
|
Jeronimo Martins SGPS SA
ELI:JMT
|
PT |
|
P
|
Philip Morris CR as
PSE:TABAK
|
CZ |
|
Uniper SE
OTC:UNPRF
|
DE |
|
E
|
Eskay Mining Corp
F:KN7
|
CA |
|
P
|
Pan African Resources PLC
OTC:PAFRF
|
UK |
Bankruptcy Probability
GSK plc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
GSK plc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
GSK plc
XETRA:GS71
|
83.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
622.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
352.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
159.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
336.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
GSK plc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, GSK plc has total debt of 13.9B GBP. This includes both short-term (0 GBP) and long-term (13.9B GBP) debt.
You can find a full breakdown on its Balance Sheet.